Suchergebnisse - "Mantoan, Beatrice"

PubPharm (22)

1

Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy

enthalten in: Clinical colorectal cancer | 2024

von Giuliani, J. | Mantoan, B. | Mangiola, D. | +5

2

The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs

enthalten in: Recenti progressi in medicina | 2023

von Giuliani, J. | Mantoan, B. | Candela, M. | +4

3

Cost-effectiveness of pembrolizumab in first-line for microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancerF

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Giuliani, J. | Mandara, M. | Mantoan, B. | +5

4

Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Giuliani, J. | Mantoan, B. | Ferrario, L. | +2

5

Cost-effectiveness of programmed death ligand-1 (PD-L1) blockade in first-line for metastatic gastric/gastroesophageal junction cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Giuliani, J. | Mantoan, B. | Bonetti, A.

6

Whey proteins isolate supplementation in additional to nutritional counseling in cancer patients

enthalten in: Recenti progressi in medicina | 2022

von Giuliani, J. | Vignale, F. | Mantoan, B. | +1

7

Long-term survivors of metastatic colorectal cancer treated with trifluridine/tipiracil

enthalten in: Recenti progressi in medicina | 2022

von Giuliani, J. | Mantoan, B. | Bonetti, A.

8

The cost-effectiveness of new first-line therapies approved in advanced hepatocellular carcinoma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Giuliani, J. | Mantoan, B. | Bonetti, A.

9

Cost-effectiveness of maintenance therapy after first-line treatment in metastatic colorectal cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Giuliani, J. | Mantoan, B. | Bonetti, A.

10

Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Giuliani, J. | Mantoan, B. | Bonetti, A.